Skip to main content
Clinical Trials/JPRN-UMIN000053018
JPRN-UMIN000053018
Not yet recruiting
未知

Cognitive Behavioral Therapy as an Intervention to Prevent Weight Rebound post Semaglutide Discontinuation - REBOUND-STOP

kansai medical university0 sites40 target enrollmentJanuary 1, 2024
ConditionsObesity

Overview

Phase
未知
Intervention
Not specified
Conditions
Obesity
Sponsor
kansai medical university
Enrollment
40
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 1, 2024
End Date
March 31, 2026
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who fall under any of the following will not be included in this study. 1\) Patients with severe hepatic or renal dysfunction 2\) Pregnant and lactating women 3\) Patients with malignant tumor 4\) Patients with severe heart failure/arrhythmia 5\) Patients with secondary obesity due to endocrine (hormone) or other drugs, etc. 6\) Patients with a history of hypersensitivity to semaglutide 7\) Patients with diabetic ketoacidosis, diabetic coma or precoma, type 1 diabetes 8\) Severe infections in patients with type 2 diabetes, conditions requiring emergency surgery, etc. 9\) Other patients deemed unsuitable as research subjects by the research director

Outcomes

Primary Outcomes

Not specified

Similar Trials